Next 10 |
2024-04-23 11:37:17 ET Summary Spero Therapeutics, Inc. has continued to build and advance its pipeline over the past several months and is now on the verge of generating landmark data with multi-bagger potential. Spero has excellent downside protection and additional upside from ...
2024-03-15 16:45:20 ET More on Spero Therapeutics Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M Read the full article on Seeking Alpha For further details see: Spero Therapeutics files $300M mixed securities shelf
2024-03-14 09:22:00 ET DENVER, Colo., Mar 14, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Lithium Americas Corp. (NYSE: LAC ), Robinhood Markets, Inc. (NASDAQ: HOOD ), Brera Holding ( NASDAQ:BREA ), Spero Therapeutics, Inc. ...
2024-03-14 09:06:04 ET DENVER, Colo., Mar 14, 2024 ( 247marketnews.com )- Spero Therapeutics, Inc. (NASDAQ: SPRO ) reported its fourth quarter and full year 2023 financial results, and provided a business update. “2023 was a productive year for Spero and we have been...
2024-03-13 17:45:09 ET Spero Therapeutics, Inc. (SPRO) Q4 2023 Earnings Conference Call March 13, 2024, 04:30 PM ET Company Participants Michael Wood - Managing Director of LifeSci Advisors Sath Shukla - CEO Kamal Hamed - CMO Esther Rajavelu - CFO and Chief B...
2024-03-13 16:18:52 ET More on Spero Therapeutics Spero Therapeutics Q4 2023 Earnings Preview Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M Seeking Alpha’s Quant Rating on Spero Therapeutics Historical earnings d...
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024 Initiated enrollment in PIVOT-PO, a pivotal Phase 3 clinical trial of oral Tebipenem HBr in cUTI Submitted IND f...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...
2024-03-12 17:35:56 ET More on Spero Therapeutics Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M Seeking Alpha’s Quant Rating on Spero Therapeutics Historical earnings data for Spero Therapeutics Financial informa...
2024-03-12 17:35:31 ET Major earnings expected after the bell on Wednesday include: UiPath ( PATH ) SentinelOne ( S ) Lennar Corporation ( LEN ) GrowGeneration Corp. ( GRWG ) Limbach Holdings ( LMB ) Read the full article on Seeking Alpha ...
News, Short Squeeze, Breakout and More Instantly...
Spero Therapeutics Inc. Company Name:
SPRO Stock Symbol:
NASDAQ Market:
Spero Therapeutics Inc. Website:
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial re...
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metr...
2024-03-14 09:22:00 ET DENVER, Colo., Mar 14, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Lithium Americas Corp. (NYSE: LAC ), Robinhood Markets, Inc. (NASDAQ: HOOD ), Brera Holding ( NASDAQ:BREA ), Spero Therapeutics, Inc. ...